Sputtr.com | Alternative Search Engine

Janssen

XARELTO® is the only new oral anticoagulant with FDA ...

Page 1 of 5 FDA Approves XARELTO ® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery XARELTO ® is the only new oral anticoagulant with FDA approval in this indication Raritan, NJ (July 1, 2011) — Janssen Pharmaceuticals, Inc ...

FOR IMMEDIATE RELEASE Ortho-McNeil-Janssen Pharmaceuticals ...

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL ® Tablets and One Lot of Risperidone Tablets . Titusville, N.J., June 17, 2011 – Ortho-McNeil-Janssen Pharmaceuticals, Inc. is

JANSSENPMP SPECIALTY CHEMICALS

Janssen PMP has an extensive range of metal-free and organic compounds that are active against microbial organisms and insects. In addition to their application in our core functional areas including Food Chain Management, Wood Protection and Antifouling, our compounds offer valuable control of ...

No. 1-09-3562, DiCosolo v. Janssen Pharmaceuticals, Inc ...

I LLINOIS O FFICIAL R EPORTS Appellate Court DiCosolo v. Janssen Pharmaceuticals, Inc. , 2011 IL App (1st) 093562 Appellate Court Caption JOHN DiCOSOLO, as Administrator of the Estate of Janice V. DiCosolo, Deceased, Plaintiff-Appellee, v.

Patient Guide for use of the

Janssen-Cilag Pty Ltd 1-5 Khartoum Rd North Ryde NSW 2113 Australia NZ Office: Auckland New Zealand Manufactured by: Johnson & Johnson do Brasil Indústria e Comércio de Productos para Saúde Ltda. Rodovia Presidente Dutra, Km 154 Sao Jose Dos Campos, Sao Paulo, 12240-908 BRAZIL For: Ortho McNeil ...

Introducing a new brand in Australia

MEDIA RELEASE DATE: 29 OCTOBER 2010 Introducing a new brand in Australia We are Janssen. We are one team, working together on behalf of patients every day.

PRODUCT MONOGRAPH

For Consumer Information Click Here PRODUCT MONOGRAPH N DURAGESIC * 12 N DURAGESIC * 25 N DURAGESIC * 50 N DURAGESIC * 75 N DURAGESIC * 100 fentanyl transdermal system Opioid Analgesic This Product Monograph is the exclusive property of Janssen-Ortho Inc.

Program - Patients must read this and sign the acknowledgment ...

manage this program, the Companies working on Janssen Biotech's behalf, in connection with the Program, may contact me to verify information about my patient’s treatment with REMICADE

PRODUCT MONOGRAPH

or by contacting the sponsor, Janssen Inc., at: 1-800-567-3331 . This leaflet was prepared by . Janssen Inc. Markham, Ontario L3R 0T5 . Date of issuance: Dec 2010

What’s Happening

Janssen’s will be closed New Year’s Day . Monday, January 30, 2012. Soups: